RecruitingNot ApplicableNCT04558723

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy

Randomized Controlled, Multi-centre Trial of Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy


Sponsor

Prof. Dr. med. Ingo Eitel

Enrollment

760 participants

Start Date

Jan 14, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with diagnostic CMR images for assessment of LGE/fibrosis and evidence/presence of non-ischaemic myocardial fibrosis/scar will be randomized to the following treatment groups in a 1:1 ratio: ICD group or Optimal HF care group.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • NIDCM (idiopathic or familial)\*
  • LVEF ≤35% and presence of fibrosis on CMR
  • Diagnostic CMR scan
  • Age ≥18 years
  • Written informed consent
  • Ability to give informed consent

Exclusion Criteria13

  • ICM \[previous myocardial infarction, previous percutaneous coronary intervention\]
  • Other cardiomyopathies (hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy, infiltrative cardiomyopathies \[e.g. cardiac amyloidosis, cardiac sarcoidosis, hemochromatosis and iron overload cardiomyopathy\], left ventricular non-compaction cardiomyopathy, reversible cardiomyopathies \[Takotsubo syndrrome, peripartum cardiomyopathy, chemotherapy induced cardiomyopathy\].
  • Myocarditis
  • Contraindication for CMR at study entry (including severe claustrophobia, pacemaker or ICD, metallic cerebral or intracranial implants, known allergy to gadolinium)
  • Severe renal insufficiency (creatinine clearance \<30 mL/min)
  • Current pacemaker or defibrillator in situ
  • Current indication for device therapy (e.g. secondary prophylaxis after aborted SCD)
  • Renal impairment defined as an eGFR \<30 milliliters
  • Age \<18 years
  • Patients presenting with pregnancy
  • Patients without informed consent
  • Participation in another randomized trial
  • Life expectancy \<2 years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERICD/CRT-D implantation

ICD/CRT-D implantation (if indicated)


Locations(1)

Universität zu Lübeck

Lübeck, Schleswig-Holstein, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04558723


Related Trials